Skip to main content
Premium Trial:

Request an Annual Quote

Wafergen Inks Agreement to Move European HQ to Luxembourg


Wafergen Biosystems said this week that it has reached an agreement with the Luxembourg government to locate its European headquarters in the country.

Wafergen said that the agreement would support the commercialization strategy for its SmartChip Real-Time PCR system, due to launch later this year.

The new Luxembourg location will house Wafergen's European marketing and sales, service and support, distribution, management of any subsidiaries and distributors, IP management, and some R&D activities, the company said.

Wafergen said that it has discussed with the Luxembourg government the potential role of the SmartChip system and other gene-analysis programs in Luxembourg's $200 million biomedical initiative, launched in 2008, which aims to harness genomics technologies to study human health problems.

"This is another important step in our commercialization strategy and combines with the receipt of a CE Mark for the SmartChip system and our collaboration at Ghent University in Belgium to further our international sales expansion," Wafergen Chairman and CEO Alnoor Shivji said in a statement.

The Scan

Missed Early Cases

A retrospective analysis of blood samples suggests early SARS-CoV-2 infections may have been missed in the US, the New York Times reports.

Limited Journal Editor Diversity

A survey finds low diversity among scientific and medical journal editors, according to The Scientist.

How Much of a Threat?

Science writes that need for a provision aimed at shoring up genomic data security within a new US bill is being questioned.

PNAS Papers on Historic Helicobacter Spread, Brain Development, C. difficile RNAs

In PNAS this week: Helicobacter genetic diversity gives insight into human migrations, gene expression patterns of brain development, and more.